Leap Therapeutics
LPTX
LPTX
61 hedge funds and large institutions have $14.9M invested in Leap Therapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 18 closing their positions.
Holders
61
Holders Change
-11
Holders Change %
-15.28%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
15
Reduced
16
Closed
18
Calls
$43K
Puts
$4K
Net Calls
+$39K
Net Calls Change
-$189K
Top Buyers
| 1 |
ECM
1
Element Capital Management
New York
|
$521K |
| 2 |
2
Millennium Management
New York
|
$498K |
| 3 |
3
Renaissance Technologies
New York
|
$417K |
| 4 |
6CM
4
683 Capital Management
New York
|
$1.24M |
| 5 |
BC
5
BIT Capital
Berlin,
Germany
|
$165K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CUAMC
76
China Universal Asset Management Company
Shanghai,
China
| – | – | -928 | Closed |
|
|
CG
77
Cutler Group
San Francisco,
California
| – | – | -733 | Closed |
|
|
OPW
78
Oxler Private Wealth
Rye Brook,
New York
| – | – | -544 | Closed |
|
79
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 23 | -185 | -89% |
|
80
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
81
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|